Search

Sangeeta Raje Phones & Addresses

  • 2703 Baldeagle Cir, Norristown, PA 19403 (610) 630-2148
  • Audubon, PA
  • 1804 Stone Gate Blvd, Elkton, MD 21921
  • 2100 Meadow Dr, Blue Bell, PA 19422 (610) 731-0180
  • 1515 Meadow Dr, Blue Bell, PA 19422
  • 4121 Postgate Ter #303, Silver Spring, MD 20906
  • Fargo, ND
  • Lansdale, PA

Work

Company: Pfizer 2010 to 2016 Position: Associate director, global clinical pharmacology, primary care business unit

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Maryland - Baltimore 1998 to 2002

Emails

Industries

Pharmaceuticals

Resumes

Resumes

Sangeeta Raje Photo 1

Director

View page
Location:
Norristown, PA
Industry:
Pharmaceuticals
Work:
Pfizer 2010 - 2016
Associate Director, Global Clinical Pharmacology, Primary Care Business Unit

Pfizer 2007 - 2009
Assistant Director, Clinical Pk, Early Development and Clin Pharmacology

Pfizer 2005 - 2007
Senior Clinical Pharmacokineticist, Clinical Pk, Early Development and Clin Pharmacology

Pfizer 2002 - 2005
Clinical Pharmacokineticist, Clinical Pk, Early Development and Clin Pharm

Pfizer 2002 - 2005
Director
Education:
University of Maryland - Baltimore 1998 - 2002
Doctorates, Doctor of Philosophy
North Dakota State University 1994 - 1996
Masters

Publications

Us Patents

Pharmaceutical Dosage Forms And Compositions

View page
US Patent:
20070099931, May 3, 2007
Filed:
Sep 6, 2006
Appl. No.:
11/517605
Inventors:
Krishnendu Ghosh - Sparkill NY, US
Arwinder Nagi - Thiells NY, US
Xiaohong Pan - Highland Mills NY, US
Melissa Lin - Wanaque NJ, US
Leonid Linberg - Upper Saddle River NJ, US
Ping Cai - New City NY, US
Eric Browne - Quebec, CA
Michel Bernatchez - Montreal, CA
Mark Lankau - Dollard des Ormeaux, CA
Sangeeta Raje - Audubon PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/496
US Classification:
514253110
Abstract:
The invention relates to, for example, novel formulations and methods for the delivery of 4-cyano-N-{(2R)—2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and/or metabolites; as well as to use of these formulations and methods for treating disease.

Bifeprunox Mesylate Maintenance Dose Compositions And Methods For Using The Same

View page
US Patent:
20080286258, Nov 20, 2008
Filed:
Mar 23, 2007
Appl. No.:
11/727173
Inventors:
Irene Eijgendaal - CP Weesp, NL
Gerrit Klein - CP Weesp, NL
Maria J.L. Terhorst-Van Amstel - CP Weesp, NL
Klaas Zwier - CP Weesp, NL
Nico Bruins - CP Weesp, NL
Hendrikus T. Rigter - CP Weesp, NL
Erik Gout - CP Weesp, NL
Caroline Boon - CP Weesp, NL
Michiel H. De Vries - CP Weesp, NL
Dorte Malling - Valby-Copenhagen, DK
Anneke Winsemius - CP Weesp, NL
Sangeeta Raje - Collegeville PA, US
Ellen Bech Christensen - Valby-Copenhagen, DE
Jeff Paul - Berwyn PA, US
International Classification:
A61K 38/48
A61K 31/496
A61K 33/00
A61P 25/00
US Classification:
424 9464, 51425402, 424722
Abstract:
The present disclosure provides novel pharmaceutical dosage forms such as a maintenance treatment dose and methods for making the same, and methods for using said compounds and maintenance treatment doses to treat and prevent diseases and/or disorders.

Bifeprunox Mesylate Maintenance Dose Compositions And Methods For Using The Same

View page
US Patent:
20110200687, Aug 18, 2011
Filed:
Mar 8, 2011
Appl. No.:
13/042570
Inventors:
Irene EIJGENDAAL - Weesp, NL
Gerrit Klein - Weesp, NL
Maria J.L. Terhorst-Van Amstel - Weesp, NL
Klaas ZWIER - Weesp, NL
Nico BRUINS - Weesp, NL
Hendrikus T. RIGTER - Weesp, NL
Erik GOUT - Weesp, NL
Caroline BOON - Weesp, NL
Michiel H. De Vries - Weesp, NL
Dorte MALLING - Valby-Copenhagen, DK
Anneke WINSEMIUS - Weesp, NL
Sangeeta RAJE - Collegeville PA, US
Ellen Bech CHRISTENSEN - Valby-Copenhagen, DK
Jeff PAUL - Berwyn PA, US
International Classification:
A61K 31/496
A61K 31/55
A61K 38/17
A61K 33/00
A61P 25/00
US Classification:
424722, 51425402, 514217, 514 135
Abstract:
The present disclosure provides novel pharmaceutical dosage forms such as a maintenance treatment dose and methods for making the same, and methods for using said compounds and maintenance treatment doses to treat and prevent diseases and/or disorders.
Sangeeta V Raje from Audubon, PA, age ~52 Get Report